 |
Jerusalem, Israel, August 10, 2010
Teva Completes Acquisition of ratiopharm
|
 |
Jerusalem, Israel and Valby, Denmark, August 5, 2010
TEMPO Extension Study Further Demonstrates the Benefits of Azilect® in Early Parkinson's Disease Patients
|
 |
Jerusalem, Israel, August 3, 2010
Teva Receives European Commission Approval for ratiopharm Acquisition
|
|
|
Yossi Koren
Vice president, Corporate Communications
Teva Pharmaceutical Industries Ltd.
Denise Bradley
Sr. Director, North America Corporate
Communications
Teva North America.
|